Daiichi Sankyo Limited (DSNKY)
PNK: DSNKY
· Real-Time Price · USD
25.42
-0.23 (-0.90%)
At close: May 01, 2025, 3:58 PM
-0.90% (1D)
| Bid | 25.34 |
| Market Cap | 47.52B |
| Revenue (ttm) | 1,796B |
| Net Income (ttm) | 245.77B |
| EPS (ttm) | 1.08 |
| PE Ratio (ttm) | 23.54 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 25.44 |
| Volume | 28,755 |
| Avg. Volume (20D) | 302,595 |
| Open | 25.83 |
| Previous Close | 25.65 |
| Day's Range | 25.30 - 26.31 |
| 52-Week Range | 20.92 - 42.48 |
| Beta | 0.33 |
About DSNKY
Daiichi Sankyo Company, Limited researches and develops, manufactures, imports, markets, and sells pharmaceutical products worldwide. The company offers trastuzumab deruxtecan, an anti-cancer agent and anti-HER2 antibody drug conjugate; mirogabalin for pain treatment; teneligliptin/canagliflozin for type 2 diabetes mellitus treatment; lacosamide anti-epileptic agent; prasugrel, an antiplatelet agent; denosumab for osteoporosis and bone disorders;...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Dec 12, 2008
Employees 18,726
Stock Exchange PNK
Ticker Symbol DSNKY
Website https://www.daiichisankyo.com
